Drug Patent Expirations for the Week of December 3, 2023

STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer ingelheim Patent: 7,056,916 Expiration: Dec 7, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…

The post Drug Patent Expirations for the Week of December 3, 2023 appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog